- Home
- ALAR vs NSPR Comparison
ALAR vs NSPR Comparison
Compare ALAR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- NSPR
- Stock Information
- Founded
- ALAR 2013
- NSPR 2005
- Country
- ALAR Israel
- NSPR Israel
- Employees
- ALAR N/A
- NSPR N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- NSPR Medical/Dental Instruments
- Sector
- ALAR Technology
- NSPR Health Care
- Exchange
- ALAR Nasdaq
- NSPR Nasdaq
- Market Cap
- ALAR 94.0M
- NSPR 63.0M
- IPO Year
- ALAR 2018
- NSPR N/A
- Fundamental
- Price
- ALAR $11.24
- NSPR $3.00
- Analyst Decision
- ALAR Strong Buy
- NSPR Strong Buy
- Analyst Count
- ALAR 2
- NSPR 2
- Target Price
- ALAR $24.00
- NSPR $4.75
- AVG Volume (30 Days)
- ALAR 231.4K
- NSPR 78.8K
- Earning Date
- ALAR 11-25-2024
- NSPR 11-12-2024
- Dividend Yield
- ALAR N/A
- NSPR N/A
- EPS Growth
- ALAR N/A
- NSPR N/A
- EPS
- ALAR 0.10
- NSPR N/A
- Revenue
- ALAR $31,561,000.00
- NSPR $6,821,000.00
- Revenue This Year
- ALAR $22.15
- NSPR $13.31
- Revenue Next Year
- ALAR $11.59
- NSPR $52.91
- P/E Ratio
- ALAR $10.77
- NSPR N/A
- Revenue Growth
- ALAR 40.80
- NSPR 24.70
- 52 Week Low
- ALAR $4.92
- NSPR $1.81
- 52 Week High
- ALAR $46.69
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- ALAR 40.46
- NSPR 57.02
- Support Level
- ALAR $10.41
- NSPR $2.80
- Resistance Level
- ALAR $12.34
- NSPR $3.01
- Average True Range (ATR)
- ALAR 0.76
- NSPR 0.20
- MACD
- ALAR -0.11
- NSPR -0.02
- Stochastic Oscillator
- ALAR 23.75
- NSPR 60.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.